Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsVAGINALStandard

MONISTAT 3

MICONAZOLE NITRATE

Standard Dose
200MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview MONISTAT 3 is listed in Drugs@FDA under application 018888 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient MICONAZOLE NITRATE Form and strength SUPPOSITORY;VAGINAL - 200MG Sponsor MEDTECH PRODUCTS Submission history Latest submission status date: 2014-02-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview MONISTAT 3 is listed in Drugs@FDA under application 018888 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MICONAZOLE NITRATE Form and strength SUPPOSITORY;VAGINAL - 200MG Sponsor MEDTECH PRODUCTS Submission history Latest submission status date: 2014-02-27 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.